PELLEGRITI, GABRIELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.573
EU - Europa 1.004
AS - Asia 265
AF - Africa 216
SA - Sud America 5
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.068
Nazione #
US - Stati Uniti d'America 1.496
IT - Italia 277
IE - Irlanda 253
CN - Cina 225
UA - Ucraina 203
CI - Costa d'Avorio 180
DE - Germania 95
CA - Canada 77
RU - Federazione Russa 66
SE - Svezia 37
SN - Senegal 30
GB - Regno Unito 18
FR - Francia 14
IN - India 9
VN - Vietnam 9
CH - Svizzera 8
PL - Polonia 7
SG - Singapore 6
BE - Belgio 5
NL - Olanda 5
UZ - Uzbekistan 5
BR - Brasile 4
LB - Libano 4
NG - Nigeria 4
BG - Bulgaria 3
AT - Austria 2
CZ - Repubblica Ceca 2
ES - Italia 2
EU - Europa 2
FI - Finlandia 2
GR - Grecia 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
AR - Argentina 1
AU - Australia 1
HK - Hong Kong 1
ID - Indonesia 1
IM - Isola di Man 1
IR - Iran 1
JP - Giappone 1
NO - Norvegia 1
PT - Portogallo 1
TR - Turchia 1
TW - Taiwan 1
Totale 3.068
Città #
Chandler 406
Dublin 253
Jacksonville 192
Abidjan 180
Houston 179
Grafing 76
Andover 67
Cambridge 67
Lawrence 67
Nanjing 67
Catania 66
Ashburn 62
Toronto 56
Wilmington 40
Boardman 35
Dakar 30
San Mateo 30
Des Moines 29
Nanchang 26
Hebei 21
Pescara 21
Saint Petersburg 21
Ottawa 20
Shenyang 17
Bari 15
Bremen 14
Beijing 12
Changsha 11
Quintano 11
Amantea 9
Dearborn 9
Dong Ket 9
Rome 9
Aci Castello 8
Jiaxing 8
Norwalk 8
Woodbridge 8
Seattle 7
Crema 6
Jinan 6
Moscow 6
Pune 6
Tianjin 6
Agrigento 5
Ann Arbor 5
Brussels 5
Abuja 4
Den Haag 4
Fairfield 4
Falls Church 4
Ningbo 4
Singapore 4
Villafranca Tirrena 4
Bovalino 3
Leawood 3
Liberty Lake 3
Manduria 3
Oristano 3
Padova 3
Redwood City 3
San Francisco 3
Washington 3
Acquaviva Picena 2
Augusta 2
Edinburgh 2
Hangzhou 2
Kunming 2
Lanzhou 2
Mountain View 2
Novara 2
Piquete 2
Santa Teresa di Riva 2
Sofia 2
Terni 2
Tunis 2
Viggiano 2
Zhengzhou 2
Ardabil 1
Auckland 1
Bangalore 1
Boston 1
Buenos Aires 1
Caivano 1
Charlotte 1
Dallas 1
Douglas 1
Exeter 1
Fauglia 1
Favara 1
Ferrara 1
Fiumefreddo di Sicilia 1
Frankfurt Am Main 1
Frankfurt am Main 1
Gorgonzola 1
Grammichele 1
Groningen 1
Guangzhou 1
Hefei 1
Hyderabad 1
Ispica 1
Totale 2.319
Nome #
Time to Separate Persistent from Recurrent Differentiated Thyroid Cancer: Different Conditions with Different Outcomes 212
Chemioterapia con fluorouracile (FU) in infusione continua e vinorelbina (VNB) nel carcinoma differenziato della tiroide (CDT) in fase avanzata 100
Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis 80
Effect of low-dose tungsten on human thyroid stem/precursor cells and their progeny 77
Soggetti trattati con chemio e/o radioterapia in età pediatrica per neoplasia: patologia tiroidea (morfo-funzione) 68
Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases 61
Caratteristiche cliniche e istologiche di una serie di 23 pazienti affetti da carcinoma tiroideo della cisti del dotto tireoglosso 57
Caratteristiche istologiche alla diagnosi e decorso clinico in pazienti tiroidectomizzati per carcinoma papillare variante sclerosante diffusa: studio di metanalisi. 56
Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution 55
[Differentiated carcinoma of the thyroid in the young. Clinical and histopathologic aspects] 55
BRAF T1799A Mutation in Thyroid Cancer Predicts Progressive disease 53
A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma 53
Absorbed Dose Evaluation in Radioiodine Therapy with Different Approaches 53
Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer 53
Caratteristiche istologiche e cliniche della variante sclerosante diffusa del carcinoma papillifero tiroideo 52
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 52
BRAF(V600E) mutation and the biology of papillary thyroid cancer 51
Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods 51
Editorial: Clinical and molecular epidemiology of thyroid cancer of follicular origin 51
Papillary Thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries 50
Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors 49
Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 49
Papillary thyroid cancer incidence in the volcanic area of Sicily 48
Early occurrence of a thyroid carcinoma in a patient who developed Graves’ disease after treatment for Hodgkin’s disease 48
Ruolo prognostico dello status linfonodale alla diagnosi sull’evoluzione clinica di 4292 pazienti tiroidectomizzati per carcinoma differenziato della tiroide (CDT). 45
Differentiated thyroid cancer in children and adolescents 45
Long-term outcome of patients with insular carcinoma of the thyroid 45
Worldwide increasing incidence of thyroid cancer:update on epidemiology and risk factors 44
Several site-specific cancers are increased in the volcanic area in Sicily 44
Increased mortality in patients with differentiated thyroid cancer associated with graves' disease 44
Impact of post-operative radioiodine remnant abalation in differentiated thyroid cancer according to risk categories. 43
Risk-stratified evaluation of over 16000 thyroid microcarcinomas: at presentation more than one third have two or more risk factors for recurrence. 43
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome 42
Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment 42
Outcome of differentiated thyroid cancer in Graves' patients 42
Increased thyroid cancer incidence in volcanic areas: A role of increased heavy metals in the environment? 41
The diagnostic use of the rh-TSH thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels 40
EP-1773 Radioiodine therapy: a dosimetric study in a patient with DTC after rhTSH stimulation 40
Risk of benign and malignant thyroid disorders in subjects treated for paediatric/adolescent neoplasia: Role of morphological and functional screening 40
Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer 39
Response to Letter to the Editor: "Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes" 39
Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas 39
Persistenza vs Recidiva di malattia nel Carcinoma Differenziato della Tiroide 39
Lymph node location is a risk factor for papillary thyroid cancer-related death 38
Valore predittivo del dosaggio della tireoglobulina sierica alla prima valutazione post-tiroidectomia nei pazienti con carcinoma papillifero della tiroide di piccole dimensioni 37
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 36
TSH ricombinante umano nei pazienti con carcinoma tiroideo differenziato: utilità del follow-up a breve e a lungo termine 35
Mortality of differentiated thyroid cancer in Graves’s patients. 35
Metastatic malignant struma ovarii with coexistence of Hashimoto’s thyroiditis 34
The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome. 34
Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients 34
Utilità del dosaggio ultrasensibile della tireoglobulina per il follow-up dei pazienti con carcinoma tiroideo differenziato classificati per livello di rischio di recidiva. 33
Occurrence of distant metastates as the first sign of disease is a strong prognostic factor of poor outcome in patients with differentiated thyroid cancer 33
Prognostic significance of serum Tg in differentiated thyroid cancer (DTC) patients before 131-I ablation and its correlation with neck 131-I uptake. 33
Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin. 31
Thyroglobulin measurements after rhTSH stimulation in the follow-up of patients with differentiated thyroid cancer 31
Thyroid cancer in thyroglossal dust cyst requires a specific approach due to its unpredictable extension. 31
Thyroid Tumor Registry of Sicily: Molecular Epidemiology 29
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes. 29
Thyroid cancer in thyroglossal duct cysts requires a specific approach due to its unpredictable extension. 29
Usefulness of rhTSH in the management of differentiated thyroid cancer 28
Proposta di modifica della stadiazione TNM dei pazienti con carcinoma tiroideo a bass rischio (stadio I). 28
Chemotherapy with continous infusion of fluorouracil (FU) and vinorelbine (VNB) in advanced differentiated thyroid cancer (DTC) 28
Update on thyroid cancer treatment 28
Usefulness of recombinant human TSH (rhTSH) in the radiometabolic treatment of selected thyroid cancer patients 25
Orbital metastasis from thyroid cancer: a case report and review of the literature 23
Long-term outcome in patients with differentiated thyroid cancer and skull metastases 23
Type I gastric carcinoid in a young woman with polyglandular autoimmune syndrome type III. 2013 23
Is multifocality a risk factor in low-risk papillary thyroid cancer? 17
Heavy Metals in the Environment and Thyroid Cancer 16
Prognostic factors for adrenocortical carcinoma outcomes 15
Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol 13
Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM 9
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: A 2015 position statement of the Italian Society of Endocrinology 6
Reply to the Letter to the Editor by Sollini M et al 1
Totale 3.175
Categoria #
all - tutte 9.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.738


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201929 0 0 0 0 0 0 0 0 0 0 0 29
2019/2020509 144 34 46 50 75 23 32 1 32 8 41 23
2020/2021442 5 31 42 7 106 13 41 8 104 7 46 32
2021/2022484 60 70 3 12 71 2 73 17 46 0 15 115
2022/20231.056 71 67 16 135 98 153 19 193 235 8 32 29
2023/2024466 30 94 20 33 23 166 0 76 9 15 0 0
Totale 3.175